Warner Chilcott Files Lawsuits for Infringement of DORYX... ( ST. DAVID'S Bermuda Dec. 23 /- Warner...)

Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent

Date:12/27/2008

ST. DAVID'S, Bermuda, Dec. 23 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed lawsuits against each of Mutual Pharmaceutical Company, Inc. ("Mutual"), Mylan Pharmaceuticals Inc. ("Mylan") and Impax Laboratories, Inc. ("Impax") in the District Court for the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161 (the "'161 Patent") which covers DORYX, a tetracycline-class oral antibiotic. Warner Chilcott markets and sells DORYX delayed-release tablets in 150, 100 and 75 mg strengths under a license agreement with Mayne.

The lawsuits are in response to the submission of Abbreviated New Drug Applications ("ANDAs") to the U.S. Food and Drug Administration ("FDA") by each of Mutual, Mylan and Impax requesting approval to manufacture and sell generic versions of DORYX 100 and 75 mg delayed-release tablets prior to the expiration in 2022 of the '161 Patent. Warner Chilcott and Mayne intend to vigorously defend the '161 Patent and pursue their legal rights.

About Warner Chilcott

Warner Chilcott is a specialty pharmaceutical company focused on developing, manufacturing, marketing and selling branded prescription pharmaceutical products in women's healthcare and dermatology in the U.S. WCRX-G.

Read more on www.warnerchilcott.com.

Warner Chilcott's Forward Looking Statements:

This press release contains forward-looking statements, including statements concerning our product development efforts. These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securitie
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimers and Other Cognitive Disorders
2. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
3. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
4. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
5. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
6. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
7. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
8. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
9. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
10. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
11. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules

Post Your Comments:

(Date:11/30/2009)... , NEW YORK, Nov. 30 Reportli...rt is available in its catalogue: ,, Outsourci...4) ,, http://www.reportlinker.com/p0165747/Ou... ,, Report Description ,, Medical devices ...ector with an estimated size of $250 billion in 20...

(Date:11/30/2009)... MT. LAUREL, N.J., Nov. 30 /PRNewswire-FirstCall...rovider of technology-enabled clinical documentati... at the Radiological Society of North America (RSN...r Radiology, the product leverages SpeechQ(TM), th...on application used by thousands of radiologists. ...

(Date:11/30/2009)..., COVINA, Calif., Nov. 30 StemCyt...ialization agreement with Academia Sinica, the Nat...y methods and Intellectual Property (IP) related t... This method and IP was pioneered by a team led b...mia Sinica. Professor Lin is currently the exclus...

[0] Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014)[0] MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention [0] StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke

... Inc.,(Nasdaq: OREX ) today announced changes to...s on its late-stage obesity programs and realign i...se changes are as follows: , -- The explora...(zonisamide and olanzapine to mitigate antipsychot...e and naltrexone to reduce symptoms of obsessive-,...

...ublished in,EuroIntervention showed that the expec...r with the MitraClip(R) system to correct mitral r...y significant mitral stenosis. Additionally,with t...d with the,MitraClip(R) system required surgery fo...rences were reported between the use of one or two...

Other Medicine Technology:Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 2 Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 3 Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 2 Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 3 Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 4

Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System

(Date:12/1/2009)... Amadeus will operate as a division of Xybion...lls, NJ (PRWEB) December 1, 2009 -- Xybion Corpora...uisition of all operating assets of Quebec City ba... of enterprise governance, risk, compliance and qu... a corporate performance management organization h...

(Date:12/1/2009)... Recent Reviews In Major Peer Review Journals...ising New Developments For The Evidence-Based Asse...iculties. Some Of The Most Recent Are Listed Below...009 -- Review written by: Leesa V. Huang Ph.D. for...No. 3 November 2009. A nice synopsis of this artic...

(Date:12/1/2009)... The Daniel Jordan Fiddle Foundation, a natio...p, advocate for, and support programs and services...isorders (ASD), has released a free informational ...zures: How To Recognize The Signs and Basic First... New York, NY (PRWEB) December 1, 2009 -- Statisti...

(Date:12/1/2009)...inn., Dec. 1 "The patient will see... for Blue Cross and Blue Shield of Minnesota,s 10,...he first Minnesotans - and the first in the contin...e(SM). Online Care Anywhere allows patients to acc...ng onto a computer or picking up the phone. Blue C...

(Date:12/1/2009)..., SHENZHEN, China, Dec. 1 /PRNewswire-Asia-Fi...SE: NPD ) ("Nepstar" or "the Company"), the larg...umber of directly operated stores,today announced...rter ended,September 30, 2009. ,, Financi...terminated a voting rights assignment agreement,w...

[0] Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions [0] Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV [0] Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure [0] Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM)[0] China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009

...estern University about the effects of epidural pa...at epidural analgesic given at the early stages of...n delivery. 728 pregnant ladies in their final ...s of labor tended to be in labor for less time and...

...d in traditional Indian medicine to treat diabetes...in a manner similar to prescription drugs. The ...salacia oblonga, which is native to regions of Ind..., the sugar that circulates throughout the body. I...

...ffect of diseases on contact with children it was ...s likely to get the kind of affection other kids r... HIV-positive parents report avoided certain types...en their own conditions. Researchers talked wit...

...dden emotional stress can result in severe but rev...c heart attack.// Stress cardiomyopathy is oft...According to the researchers, patients have actual...ypical heart attack including chest pain, fluid in...

...betes begins in Chennai today. The theme for the c...tions //and over 1000 doctors and researchers will...ld. The world congress for diabetes is held...three-day event that draws support from World Heal...

...dy researchers say the arthritis drug rofecoxib (V...k. For the study researchers looked at health reco...er had a heart attack when the research started. A...xicam, and the COX-2 inhibitor celecoxib (Celebrex...

Other Medicine News:

Epidural given in early labor may not lead to caesarian birth Herb Found To Be Effective In Controlling Blood Sugar Levels HIV-positive Parents Require More Counseling Sudden Stress Found To Mimic Heart Attack Symptoms Chennai Plays Hosts To The Diabetes World Congress Arthritis Drug – Rofecoxib , Found To Increase Heart Attack Ris

Pacemaker Follow-Up Service

PROTG® GPS™ Self-Expanding Nitinol Stent

Assay Development

Coat-Block-Run Conjugation Kit pH 8-11

Medicine Products:

Pacemaker Follow-Up Service PROTG® GPS™ Self-Expanding Nitinol Stent Assay Development Coat-Block-Run Conjugation Kit pH 8-11

Warner Chilcott Files Lawsuits for Infringement of DORYX...( ST. DAVID'S Bermuda Dec. 23 /- Warner...),Health